Is It Time To Reconsider Amdocs (DOX) After A 22% Share Price Slide?

• If you are wondering whether Amdocs is starting to look like value after a weaker share price, this article will help you weigh what the current price actually offers you.
• The stock last closed at US$66.92, with returns of a 2.6% decline over 7 days, an 8.8% decline over 30 days, a 16.5% decline year to date, and a 21.6% decline over the past year.
• Recent coverage around Amdocs has focused on its role as a software and services provider to telecom and media companies. This keeps attention on how stable its customer relationships and contract pipeline might be. Investors have also been watching how this positioning fits into longer term digital transformation budgets for its clients, which can influence sentiment when the share price moves.
• Despite those share price declines, Amdocs currently holds a valuation score of 6 out of 6 on our checks. This signals that every one of our six valuation tests currently points to undervaluation. Next we will look at how different valuation approaches line up for Amdocs, and later in the article we will get to an even more complete way to think about its value beyond any single model.

Find out why Amdocs's -21.6% return over the last year is lagging behind its peers.

Approach 1: Amdocs Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company might be worth by projecting its future cash flows and then discounting those back to today’s value. In this case, the model used for Amdocs is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections.

Amdocs recently reported last twelve month free cash flow of about US$758.0 million. Analyst inputs and extrapolations point to projected free cash flow of US$645.6 million in 2026 and US$956.5 million in 2030, with further estimates extending out to 2035. All of these projections are in US$, and amounts remain below US$1b, so they sit in the hundreds of millions range each year.

When all of these projected cash flows are discounted back, the model arrives at an estimated intrinsic value of US$126.88 per share. Compared with the recent share price of US$66.92, this suggests the stock appears about 47.3% undervalued based on this DCF set up.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Amdocs is undervalued by 47.3%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Amdocs.

Approach 2: Amdocs Price vs Earnings

For a profitable company like Amdocs, the P/E ratio is a useful shorthand because it links what you pay directly to the earnings the business is currently generating. Investors typically expect higher P/E ratios when they see stronger earnings growth potential and lower perceived risk, and lower P/E ratios when growth expectations are more muted or risks are higher.

Amdocs is currently trading on a P/E of 12.6x. That sits below the IT industry average P/E of 20.4x and slightly below the peer group average of 13.0x. Simply Wall St also calculates a proprietary “Fair Ratio” for Amdocs of 25.7x, which is the P/E level suggested by factors such as its earnings growth profile, industry, profit margins, market cap and specific risk characteristics.

This Fair Ratio is more tailored than a simple comparison with peers or the broad industry because it looks at the mix of growth, risk and profitability that is specific to Amdocs, rather than assuming that all IT stocks deserve similar multiples. With the current P/E of 12.6x sitting well below the Fair Ratio of 25.7x, this approach indicates that the shares may be undervalued on an earnings basis.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Amdocs Narrative

Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives, which are Simply Wall St tools on the Community page that let you spell out your story for Amdocs, link that story to specific forecasts for revenue, earnings and margins, arrive at your own fair value, and then compare that fair value with the current price. This can help you decide whether you think Amdocs looks attractive or expensive. Each Narrative updates automatically when fresh news or results come in. One investor might build a Narrative that leans on the higher fair value of about US$104.00 and assumes stronger adoption of cloud, AI and 5G related services. Another might prefer a more cautious view closer to the current Simply Wall St fair value of about US$93.82 that gives more weight to risks around client concentration and slower SaaS scaling.

Do you think there's more to the story for Amdocs? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com